Walmart Q2 2025 Earnings: Revenue Surges 4.8% as E-Commerce Sales Jump 25%
The Big Picture Walmart just delivered another strong quarter, and the numbers tell a clear story: the world’s largest retailer isn’t slowing down anytime soon. In Q2 2025, Walmart reported a 4.8% year-over-year revenue surge, fueled largely by a 25%…
Costco Wholesale Corporation (COST) – Stock Analysis
Costco Wholesale Corporation (NASDAQ: COST) is more than just a membership-based warehouse club — it’s a retail experience built on value, trust, and loyalty. Known for its no-frills shopping environment, bulk product offerings, and unbeatable prices, Costco has cultivated a…
Lam Research Corporation (LRCX) Stock Analysis: Enabling the Next Generation of Chips
For decades, Lam Research Corporation (NASDAQ: LRCX) has been a critical enabler of the semiconductor industry, providing the etching, deposition, and cleaning equipment essential to manufacturing advanced integrated circuits. Founded in 1980 and headquartered in Fremont, California, Lam has built…
Target Corporation (TGT) Stock Analysis: A Bold Retail Brand in a Competitive Market
For more than a century, Target Corporation (NYSE: TGT) has stood as one of the most recognizable names in U.S. retail, blending style, value, and convenience. Founded in 1902, the company has grown into a nationwide chain with over 1,950…
Netflix (NFLX) Stock Analysis: Navigating the Streaming Wars and a New Era of Profitability
Netflix, Inc. (NASDAQ: NFLX) is the company that pioneered the streaming revolution. It began as a scrappy DVD-by-mail service that dared to challenge the dominance of video rental stores and cable television. In the two decades since, it has transformed…
Gilead Sciences (GILD) Stock Analysis: A Deep Dive into the Biotech Giant’s Oncology Pivot
Gilead Sciences, Inc. (NASDAQ: GILD) is a name synonymous with some of the most significant medical breakthroughs of the last two decades. The company’s pioneering work in virology has transformed the treatment of diseases like HIV and hepatitis C, turning…
